VKTX 241206 57.00C (VKTX241206C57000) Stock Options, News & Quotes

US OptionsDetailed Quotes

VKTX241206C57000

Watchlist

0.25
-0.30-54.55%

15min DelayClose Dec 2 16:00 ET

0.40High0.15Low

Intraday

5D
Daily

News

Corbus, Viking Initiated at Overweight by Piper Sandler
Seeking Alpha13:34 ET
This Autodesk Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
BenzingaDec 2 08:56 ET
Piper Sandler Initiates Coverage On Viking Therapeutics With Overweight Rating, Announces Price Target of $74
BenzingaDec 2 05:48 ET · Ratings
Piper Sandler Initiates Viking Therapeutics(VKTX.US) With Buy Rating, Announces Target Price $74
Moomoo NewsDec 2 05:34 ET · Ratings
Express News | Viking Therapeutics Inc : Piper Sandler Initiates Coverage With Overweight Rating; Price Target $74
ReutersDec 2 04:16 ET
Viking Therapeutics Stock On Brink Of Death Cross As Weight Loss Hype Loses Momentum
BenzingaNov 29 08:42 ET

Comments

Shaaaw

Nov 27 06:52

Today, $Amgen (AMGN.US)$ announced the P2 trial results for MariTide, which only include the safety profile for the 420 mg dose escalation cohorts (cherry-picking at it's finest again).
I suspect they chose not to present the full safety profile, given that the weight loss results for the 120 mg and 280 mg QM cohorts, in obese non-diabetics (without dose escalations), at week 16 in P2 are consistent with the P1 results (see slide 1). So, it is likely that the 120 mg and 280 mg QM (without dose...